SanBio Company Limited (4592.T) — English Disclosures

SanBio Company Limited (4592.T) Growth Market

All TDNet disclosures translated to English by Pulse News Wire.

Disclosures

Jan 9, 2026 — Mar 25, 2026

Date Range

GROWTH

Market Segment

Disclosures

Date	Type	Headline	PDF
Mar 25	Equity Issuance	SanBio Company: SanBio Reports FY2026 Loss Amid R&D Costs; Seeks Global Leadership in Regenerative Medicine	PDF
Mar 17	Dividend	SanBio Company: SanBio to Reduce Capital and Transfer Surplus Reserves Amid Loss Carryforward	PDF
Mar 17	Equity Issuance	SanBio Company: SanBio Reports Non-operating Expenses and Tax Adjustments for FY2025-2026	PDF
Mar 17	Earnings	SanBio Company: Reports Earnings Results	PDF

Disclosure Types

Equity Issuance: 2 Dividend: 1 Earnings: 1

Frequently Asked Questions

Where can I read SanBio Company Limited's disclosures in English?

Pulse News Wire translates all TDNet filings for SanBio Company Limited (4592.T) to English. 4 disclosures have been translated since Jan 9, 2026.

How many disclosures has SanBio Company Limited filed on TDNet?

Pulse News Wire has translated 4 disclosures for SanBio Company Limited since Jan 9, 2026.

Does SanBio Company Limited publish English IR materials?

No. SanBio Company Limited is listed on the GROWTH Market and has no English disclosure requirement. Pulse News Wire is the only English-language source for these filings.

What types of disclosures has SanBio Company Limited filed?

SanBio Company Limited has filed the following types of disclosures on TDNet: Equity Issuance (2), Dividend (1), Earnings (1).

English translations for all 4,436 JPX-listed companies.

Including the 2,300 Standard and Growth Market companies with no other English source.

See Pricing Browse Articles